Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DENV-3-LVHC Challenge Model
NCT04298138Phase 1Completed
- Sponsor
- Upstate Medical University
- Start
- Aug 2020
- Primary completion
- Dec 2021
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 1, open-label trial of DENV-3-LVHC-State University of New York - Upstate Medical University in dengue fever (3 arms), sponsored by Upstate Medical University. Primary endpoints: Number of Abnormal Laboratory Measurements at 28 days, Occurrence of Solicited Injection Site Symptoms at 7 days and 2 more. Started Aug 2020; status: completed.
02
Drugs
DENV-3-LVHC-State University of New York - Upstate Medical University
03
Conditions
dengue fever
Beyond the preview
Go deeper on NCT04298138.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04298138.